Specialty Certificate Examination March 2009
Reminder: Pandemic influenza guidance for renal units
The CKD eGuide is derived from the NICE, SIGN, and Renal Association guidelines.
Any abnormal proteinuria is a significant risk factor for both renal disease and for cardiovascular morbidity and mortality. Unlike haematuria, proteinuria almost always has a renal origin. Management should include
The risk of renal failure is greater in younger patients. The risk of dying from heart disease is greater in older patients. Risks may be altered by therapy.
A number of thresholds have been recommended, as summarised here:
|
ACR (mg/mmol) |
PCR (mg/mmol) |
Implication |
| >2.5/3.5 | >15 | Abnormal (ACR values are for male, female): adequate to define CKD 1 or 2. |
| 30 | 50 | Favour ACE inhibitor/ ARB if hypertensive Commence ACEI/ARB if diabetic Suffix 'p' on CKD stage |
| 70 | 100 | Stricter BP limits apply Referral threshold in non-diabetics |
| >250 | >300 | Approximately 'nephrotic range' proteinuria |
Long term implications are important when considering assessment and management. For example, young adults will have many more years at risk and lower levels of proteinuria are more important.
Ratios at lower levels than above
Bearing in mind the above, usually manage as CKD, according to stage:
In patients with diabetes
Microalbuminuria (ACR>2.5/3.5)* is an indication for
Information for patients
Information for patients about proteinuria from EdREN.
Information for patients about haematuria from EdREN.
* error corrected 30.6.09. Previously stated 30mg/mmol: should read 2.5/3.5 (male/female). Thanks to Andrew Moncrief for pointing this out. NT